Lipo-C (Lipotropic Complex) is a weight management research compound currently in stock directly from a verified Chinese manufacturer. Every batch is HPLC-verified and shipped with a Certificate of Analysis (COA). Sourcing is direct — no intermediaries. Minimum order value is $600 USD. International shipping available.
Lipo-C Lipotropic Complex is a combination injectable formulation containing lipotropic agents — compounds that facilitate fat transport, metabolism, and hepatic clearance. The core formulation includes the MIC combination (Methionine, Inositol, Choline) with Cyanocobalamin (Vitamin B12), and may include additional components such as L-Carnitine, Riboflavin (B2), Thiamine (B1), and Dexpanthenol (B5) depending on formulation variant. These components collectively target hepatic fat metabolism, mitochondrial fatty acid transport, and cellular energy production pathways.
Each component has a defined metabolic role: Methionine is an essential amino acid and major methyl donor via the SAM cycle, required for phosphatidylcholine synthesis and liver fat export (VLDL assembly); Inositol is a phospholipid precursor and insulin signaling modulator; Choline is essential for phosphatidylcholine synthesis and very-low-density lipoprotein (VLDL) assembly in the liver — choline deficiency causes hepatic steatosis. B12 supports methylation reactions and neurological function. The combination addresses multiple steps in hepatic lipid handling — making it a tool for studying the intersection of methionine metabolism, choline requirements, and fatty liver biology.
PeptidesFromChina.co supplies Lipo-C Lipotropic Complex as a sterile liquid formulation at verified component concentrations. Certificate of Analysis accompanies every batch. All products are for laboratory research use only and are not for human consumption.
| Chemical Class | Lipotropic agent combination (injectable formulation) |
|---|---|
| Primary Components | Methionine, Inositol, Choline (MIC), Cyanocobalamin (B12) |
| Optional Components | L-Carnitine, Riboflavin (B2), Thiamine (B1), Dexpanthenol (B5) |
| Research Areas | Hepatic lipid metabolism, lipotropic biology, methylation research, fatty liver models, one-carbon metabolism |
| Form | Sterile liquid formulation |
| Storage | 2-8°C; protect from light; do not freeze; use within date |
| CAS Number | N/A — complex mixture |
| Molecular Weight | N/A — complex mixture |
| Molecular Formula | N/A — complex mixture |
| Sequence | N/A — complex mixture |
| Name | Strength | Pack Size | Purity | Availability | Price (USD) |
|---|---|---|---|---|---|
| Lipo-C (Lipotropic Complex) | 10 ml | 10 vials | ≥98% | In Stock | $73.00 |
Testing method: HPLC / LC-MS. Every batch is tested before shipment. Purity ≥99% confirmed per batch.
Certificate of Analysis (COA) is included with every order. Documentation covers purity, molecular weight, and batch identification.
The liver is the primary site of fatty acid synthesis, oxidation, and VLDL export. Choline deficiency is a well-established cause of hepatic steatosis (fatty liver) in rodent models — the choline-deficient diet is a standard model for NAFLD research. Lipo-C provides choline along with methionine (for SAM-dependent phosphatidylcholine synthesis) and inositol (for PI3K signaling and phospholipid synthesis), addressing the nutritional basis of hepatic lipid handling in research models.
Methionine is converted to SAM (the universal methyl donor) and then to homocysteine; remethylation of homocysteine back to methionine requires B12 and folate. Research using MIC combinations examines how methyl donor availability affects SAM-dependent reactions — including DNA methylation, histone methylation, and phosphatidylcholine synthesis via the PEMT pathway. Lipo-C provides a tool for studying one-carbon metabolism in the context of hepatic lipid biology.
L-Carnitine (when included in Lipo-C formulations) facilitates long-chain fatty acid transport across the inner mitochondrial membrane via the carnitine shuttle — the rate-limiting step for β-oxidation of long-chain fatty acids. Research has used carnitine-containing lipotropic combinations to examine how carnitine availability affects hepatic and skeletal muscle fatty acid oxidation rates, ketone production, and triglyceride accumulation in metabolic disease models.
Injectable MIC formulations deliver components systemically without hepatic first-pass metabolism, achieving higher peak plasma concentrations than oral supplementation. Choline is particularly subject to gut microbial conversion (to TMAO) and first-pass metabolism when taken orally. Research comparing parenteral versus oral MIC delivery examines bioavailability differences and downstream hepatic lipid effects.
Choline is essential for phosphatidylcholine (PC) synthesis — the primary phospholipid of VLDL lipoprotein particles. Without sufficient choline, hepatic fat cannot be packaged into VLDL for export, resulting in fat accumulation. The choline-deficient diet model is a standard NAFLD/NASH research tool. Lipo-C's choline content makes it relevant for studying choline repletion effects on hepatic steatosis endpoints.
Component concentrations are verified and stated in the Certificate of Analysis accompanying each batch. Contact us via the Request page for current batch specifications.
Lipo-C should be stored at 2-8°C, protected from light. Do not freeze (freezing may affect formulation stability). Use within the date specified on the label.
For laboratory research use only. Not for human or veterinary use. PeptidesFromChina.co is a B2B wholesale supplier operating under strict research-use-only terms. All products are sold exclusively for in vitro and preclinical research purposes.